TherapeuticsMD (NASDAQ:TXMD) reported quarterly earnings of $0.01 per share. This is a 116.67 percent increase over losses of $(0.06) per share from the same period last year. The company reported $724.000 thousand in sales this quarter. This is a 84.22 percent increase over sales of $393.000 thousand the same period last year.